It has been increasingly apparent in recent years that in addition to cases which fall into recognizable categories of muscle disease, a number of less common disorders occur from time to time which do not correspond to the accepted descriptions. Some of these appear to be metabolic in origin and can be elucidated, at least in part, by modern methods of investigation (McArdle, 1951) while others seem to fall into a borderland of either myopathy or myasthenia gravis. A case of the latter type is described and discussed below.
Case History R. M. (N. H. case 4838), a female telephonist, was born in 1919; her mother was well during pregnancy, labour was normal, and the baby thrived well during the neonatal period. She seemed normally active and lively and sat up at 7 months; at 9 months she tipped over her pram by jumping vigorously and sustained a cut chin but no other injury. Shortly after this episode her mother noticed that the limbs and body tended to flop limply when she was lifted and the head lolled as if she were totally unable to support it. The limbs were unusually flexible, like those of a rag doll, and she lay in her pram almost immobile, without kicking her legs or waving her arms. Nevertheless, at the age of a year she was able to crawl a short distance when put on the floor; her crawling improved steadily, although her limbs remained rather loose and " floppy ". However, this was her only means of locomotion until she reached the age of 5 years, when she began to pull herself up with her arms and to walk around the furniture. When she was 5j years old she was able to walk a few paces unaided and the limbs, though somewhat weak, were not so loose. The patient's mother suggested that at this age she was very little stronger but had learned to overcome her weakness. At the age of 7 she was able to go to a school for disabled children and could walk about 20 yards, but would then have to rest for about a minute in order to regain her strength. She always tended to tire throughout the day and was much weaker in the evening than on waking. She had particular difficulty in climbing stairs or in rising from a low chair and showed a considerable tendency to trip and fall, after which she would find it difficult to get up again. Apart from her muscular disability the patient developed normally; the menarche occurred at 13 years and she had menstruated normally since.
As the patient grew older she was gradually able to extend her activities, although her muscular weakness was virtually unchanged. She attempted numerous occupations and finally worked (from 1948) for two years as a telephonist, but was compelled to give up this post because of her muscular disability; since 1950 she had helped her mother in the home. The patient had two sisters, one older and one younger than herself, both of whom were well, and there was no history of muscular disease in the family.
The patient was first admitted to the National Hospital in 1941 under the care of Dr. E. A. Carmichael, when generalized muscular hypotonia of moderate degree and diffuse atrophy of proximal limb muscles were discovered. She showed an accentuated lumbar lordosis and tended to waddle when she walked. There was also bilateral ptosis and weakness of the upper facial musculature. A diagnosis of atypical amyotonia congenita was made. She was readmitted on several occasions during the ensuing years, when her symptoms and physical signs were virtually unchanged. In 1944 she was seen by Dr. Gordon Holmes, who suggested that she was suffering from an unidentified defect of muscle metabolism. In 1948 Sir Charles Symonds could demonstrate no myasthenic tiring of the eyelids, although there was pathological fatiguability of the deltoids; he agreed that the patient was suffering from an unusual metabolic disorder of muscle. On at least three occasions the effect of an intramuscular injection of 1-5 mg. prostigmine was tested. Each time the drug made the patient feel " queer " and dizzy, but nevertheless it produced some subjective improvement in muscular power, though there was little objective change. Twice the improvement in strength appeared to persist for two or three days after the injection and the drug was given by mouth in a dosage of up to 90 mg. daily. On each occasion there was a marked subjective improvement which, however, passed off after between one and two weeks and the treatment was discontinued. A similar improvement appeared to follow ephedrine, gr. On readmission under the care of Dr. Carmichael on May 6, 1955, the patient's symptoms were virtually unchanged from those she had expressed on her previous admissions, save for the fact that she had experienced occasional dysphagia when tired. However, she was still able to do housework and to walk considerable distances (with many rest periods). She felt that the muscles of her legs seemed to " let her down " less often than they had done some years before, but there had been no striking change in the condition of the limbs for many years.
On examination (Fig. 1 ) the patient was thin and slightly built and walked with a distinct waddle and with a considerable increase in the lumbar lordosis. There was bilateral ptosis, with impaired ocular movement upwards, but not laterally or downwards; the ocular axes were parallel throughout and there was no diplopia. Both orbiculares oculi were strikingly weak, but the lower facial muscles, masseters, and temporales were strong. Palatal and pharyngeal movements were normal and the tongue showed no atrophy or fasciculation. The patient had a curiously long " swan-like" neck, but the sternomastoids were large and powerful as were the posterior cervical muscles; because of the ptosis she tended to hold her head backwards. There was undoubtedly atrophy of the sacrospinalis and other posterior spinal muscles, but those of the abdominal wall were good. The limbs were generally thin, particularly proximally, and there seemed to be a general moderate atrophy, with considerable weakness, of all girdle and proximal muscles in the upper and lower limbs. The extensors of the wrist and fingers were also weak; the finger flexors were stronger but, nevertheless, considerably weaker than would have been expected in a normal individual of the patient's age. In the lower limbs the anterior tibial and peroneal groups showed the same atrophy and weakness as the proximal muscles, although the calf muscles were more powerful. All deep tendon reflexes were present, though depressed, and direct muscle excitability was normal; the abdominal reflexes were brisk, the plantar responses flexor. The Ephedrine medication and all other medicinal treatment was discontinued from the third day of this test; a creatine tolerance test was performed on the fourth day and gave results as follows:
Creatine Tolerance Test.-Urinary and blood estimations were carried out at the stated times before and after the oral ingestion of 1 g. of creatine.
RESULTS IN URINE

Volume
Creatinine Creatine Response to Insulin and Glucose.-The patient was given 100 g. glucose by mouth and 25 units of insulin subcutaneously. Before the experiment was begun the serum potassium level was 20-0 mg./100 ml., the serum inorganic phosphate level 4-5 mg./100 ml., and the blood sugar level 100 mg./100 ml. Thirty minutes after the injection, the serum potassium level was 18 3 mg./100ml., the inorganic phosphate level was unchanged, and the blood sugar level was 168 mg./100 ml.
Dr. Cumings remarked that the urinary creatine was low and almost absent when the patient was taking no drugs, while the creatine tolerance and the potassium response to insulin and glucose were all normal. The serum protein-bound iodine was 3 y %. The total serum proteins were 7T9 g./100 ml. (albumin 44, globulin 3 5).
A radiograph of the chest showed a slight dorsal scoliosis, convex to the right. The lung fields and heart were normal and the thymus did not appear to be enlarged. An electrocardiogram was normal, and a basal metabolic rate was minus 11%. The urinary 17-ketosteroid excretion was 4 9 mg. in 24 hours.
Discussion and Experiments
It was clear from the information recorded that this patient fitted no clearly recognizable form of muscle disease as previously described. The nonprogressive nature of the disease and the diffuse rather than selective distribution of muscular wasting and weakness made it apparent that she was not suffering from any of the common categories of muscular dystrophy. Furthermore, the pathological changes in the muscle were far less than would have been expected in a long-standing muscular dystrophy or polymyositis. She showed many characteristics reminiscent of the benign congenital myopathy or myopathic form of amyotonia congenita as described by Batten (1910) and by Aldren Turner (1940 Turner ( , 1949 . Because of the general reduction in size of the skeletal muscles, the resemblance to Krabbe's (1946) " congenital universal muscular hypoplasia" was even more striking, since in Turner's cases the muscular wasting and weakness affected selectively the proximal muscles of the limbs and the face was not BENIGN CONGENITAL M YOPATHY involved. Despite these discrepancies, the results of a recent follow-up of cases of amyotonia congenita by one of us (Walton, 1956) have suggested that the disorders described by Krabbe and Turner may be the same. However, in this case there were additional unusual features: the variability of her weakness, the fatiguability, which had been a consistent feature, and the apparent response to ephedrine, suggested that there might be some defect in neuromuscular transmission akin to that seen in myasthenia gravis. It was evident that the patient was not suffering from the latter disease, in view of the diffuse muscular wasting and the failure to show a sustained response to prostigmine therapy. Rowland (1955) has recently described a number of patients who appeared to be suffering from myasthenia gravis but who showed either a very variable response to prostigmine or none at all. However, from his descriptions it seems likely that some of his cases were examples of polymyositis, a condition which may show temporary improvement with this drug (Eaton, 1954) . It is clear from the clinical and pathological findings that our case was not suffering from polymyositis. An alternative possibility seemed to be that she was suffering from an unidentified disorder of muscle metabolism, although Dr. McArdle's results indicated that there was no serious defect in carbohydrate breakdown and utilization in the muscle.
In view of the apparent improvement which the patient had shown on potassium therapy it was decided to investigate the effect upon her muscular power of alterations in the serum potassium level. It was recognized that her symptoms were not like those of familial periodic paralysis, nor were they characteristic of those noted in chronic potassium deficiency (as in potassium-losing nephritis). It was also appreciated that the serum potassium level does not necessarily give a faithful indication of the intramuscular concentration of this ion. Nevertheless, since potassium is recognized to be one of the most freely diffusible ions, it was felt that if the patient's condition were due to a deficiency of intramuscular potassium, she would become significantly weaker if the serum potassium level were lowered. Another possibility seemed to be that she might have some anomaly whereby her muscles required a higher than normal concentration of potassium in order to function properly. In this case, too, a fall in extracellular potassium would increase her weakness.
It was also decided to repeat the electromyogram and to study the effects upon the muscle action potential of repetitive nerve stimulation, first under normal conditions and secondly after increasing doses of intravenous decamethonium iodide. Harvey and Masland (1941) found that in patients with myasthenia gravis, if the muscle action potential was recorded from the skin overlying a weak muscle during repetitive supramaximal stimulation of its nerve of supply at a rate of 3 per second, the potential often showed a rapid decrease in amplitude. This was suggested as a diagnostic test, and it has been conventional to take the recording from the hypothenar eminence during stimulation of the ulnar nerve at the elbow. If this muscle group is not clinically affected, however, another must be chosen. Recently, Churchill-Davidson and Richardson (1952) have shown that in the normal individual an intravenous injection of 2 mg. of decamethonium iodide will give a significant fall in amplitude of the motor unit potential recorded from the hypothenar eminence during stimulation of the ulnar nerve at a frequency of 10 per second. Patients with myasthenia gravis, however, in whom the hypothenar muscles were not weakened by the disease, were remarkably resistant to this drug and could often take 3 mg. or more without a significant decrement in the action potential.
Clearly it also seemed important in this patient to assess, under the conditions of a controlled experiment, the effect of ephedrine, prostigmine, tensilon, and potassium upon the muscular weakness. It was decided in addition to study the effects of intravenous caffeine and of calcium, in view of the direct stimulant effect which these substances appear to have upon the muscle fibre.
Before carrying out these experiments all treatment was stopped and the patient's muscular power was assessed three times daily by one of us, at 9.30 a.m., 1 p.m., and 5 p.m., in order to see whether there was any significant variation depending upon the time of day. Experiment I: Lowering of Serum Potassium Level.-On May 20, 1955, the patient was starved and 5 ml. of blood was taken from the right antecubital vein at 9 a.m.; the serum potassium level, as estimated with a flame photometer, was 4-4 mEq./litre (17-2 mg./100ml.). At 9.5 a.m. the patient was given 150 g. glucose orally and at 9.25 a.m. 25 units of insulin were given subcutaneously. At 10 a.m. muscular power was unaltered, but the serum potassium level was 41 mEq./litre (16-0mg./100 ml.). Hence the fall in serum potassium level produced by this technique was inadequate.
On May 23, 1955, after a large breakfast, the serum potassium level was estimated at 9.10 a.m. to be 4 0 mEq./litre (15-6 mg./100 ml.). At 9.20 a.m., and again at 9.35 a.m. and 9.50 a.m. the patient was given 15 g. sodium bicarbonate in 2 oz. water. At 10.30 a.m. the patient felt somewhat tired and nauseated but there was no objective change in muscle power. At 1.15 p.m. the serum potassium level was 3 12 mEq./litre (12-2 mg./100 ml.) and 1 ml. of 1 in 1,000 adrenaline was administered subcutaneously. At 2 p.m. the serum potassium level had fallen to 3-0 mEq./litre (11-7 mg./ 100 ml.) but there was still no significant change in muscular power. This technique for lowering the serum potassium level will be reported in detail by one.of us (N. G.) in a subsequent communication. with the dynamometer and by holding out the arms, increased to a level higher than any recorded since admission to hospital. The electromyogram now showed fewer polyphasic and short-duration potentials. The patient was unaware of the constitution of any of the injections she received. Experiment III: Supramaximal Stimulation of Ulnar Nerve before and after Injection of Decamethonium Iodide.-On June 4, 1955, a surface electrode was applied to the left hypothenar eminence (with the indifferent electrode on the fifth finger), and at 10 a.m. recording of the action potential produced by supramaximal stimulation of the left ulnar nerve at the elbow was begun. With a stimulation frequency of 2 per second there was no significant decrease in amplitude of the motor unit potential over a 10-minute period. Stimulation was then discontinued but was restarted at 10.20 a.m. At 10.38 a.m. 1 mg. decamethonium iodide was injected over a two-minute period. Immediately the patient felt faint and dizzy (as after " tensilon "); her ptosis increased considerably and she developed diplopia, but the action potential of the hypothenar muscles was unchanged. At 10.44 a.m. and at 10.49 a.m. two further injections, each of 0-5 mg., were given; the patient felt subjectively weaker but there was no change in the action potential. A further injection of 0-5 mg. was given at 10.54 a.m. (total 2-5 mg.); at 10.59 the action potential showed a 13 % decrease in amplitude; the patient felt weaker, was apprehensive, and refused to have further injections. The original amplitude of the action potential was restored by 11.25 a.m. With this dose of decamethonium, the action potential of a normal subject would decrease in amplitude by more than 50 %. The results of this experiment are recorded graphically in Fig. 2 ) . This trial was designed by J. A. S. so that neither the observer testing muscular power (J. N. W.), the patient, nor the ward nurses were aware which tablet was being given at any one time, nor when the treatment was changed. At the end of this period it was clear that during the three-day period of treatment with ephedrine the patient was both subjectively and objectively stronger than when she was receiving nicotinamide. Calcium.-On successive days the patient received an intravenous infusion of 500 ml. of fluid over a two-hour period. One of these infusions consisted of 500 mg. of calcium (as the gluconate) in normal saline while the other was saline alone. The observer concerned with the measurement of the patient's muscular power was not aware which infusion was being administered. After each infusion the patient claimed to be considerably stronger and showed a moderate increase in power as recorded dynamometrically and by holding the arms outstretched.
Potassium.-Over a seven-day period, from June 5, 1955, the patient was given four times a day 1 oz. of an orange-flavoured preparation. For a part of this time the preparation contained 2 g. potassium citrate in each ounce and for the remainder sodium citrate. As with the trial of ephedrine neither the patient nor the observer was aware which remedy was being given at any one time nor when the change-over occurred. Throughout this period the patient's condition remained unchanged; neither substance produced a significant change in muscular power.
Caffeine.-On June 12, 1955, the patient received three intravenous injections of comparable volume and appearance at intervals of one hour. One was caffeine sodium benzoate, 0 5 g., another ephedrine hydrochloride, gr. , and the other sterile saline. The injections were given by J. A. S. and neither the patient nor the clinical examiner (J. N. W.) was aware which injection was being given. It was discovered that the injection of saline had no effect, but both the ephedrine and the caffeine produced a distinct subjective and objective improvement in muscular strength of comparable degree.
Prostigmine.-On June 13, 1955, it was decided to study the effects of long-term oral prostigmine therapy, despite the fact that this treatment had proved ineffective in the past. Accordingly therapy with 15 mg. tablets of prostigmine four times daily was instituted, but was changed, at a time unknown to the patient and observer, to an inert tablet of identical appearance. This trial was continued over a five-day period. There was no doubt that both subjectively and objectively the patient was considerably stronger while on prostigmine. Indeed, she recorded higher dynamometer readings and was able to hold out her arms longer than at any time since her admission to hospital. During the next five days prostigmine therapy was alternated with pyridostigmine in equivalent dosage, but there was little difference in the effect of the two remedies, although overall improvement was maintained. Subsequent Progress.-As a result of the findings in the experiments outlined above it was decided to give the patient combined treatment with prostigmine, one tablet of 15 mg., four times daily, and ephedrine, one tablet of gr. i, also four times a day. For three days the improvement in the patient's strength was sustained: she moved about the ward more easily, could lift objects of considerable weight, and climbed three flights of stairs relatively briskly. Unfortunately she then developed follicular tonsillitis with a high fever and was compelled to take to her bed. This infection resolved within a few days but left the patient depressed, tearful and weak, though no weaker than she had been on admission. She asked to be discharged, feeling that she would pick up more quickly at home; she therefore left hospital, taking both ephedrine and prostigmine, on June 23, 1955. On discharge, physical examination revealed no significant change from her state on admission.
The patient was readmitted to hospital on August 9, 1955. After returning home she had improved quickly and soon felt that her strength had returned to what it was after beginning combined prostigmine and ephedrine therapy in hospital. This improvement continued for three weeks but then she began to feel unaccountably weaker. Although she had experienced some fluctuation in her muscular strength as a result of emotional disturbances, the present deterioration was quite different, being steadily progressive. In addition, she became short of breath and could no longer lie down in bed at night, or walk more than a few paces because of dyspnoea. On examination on admission the patient was unable to walk more than a few paces with considerable effort and she was quite unable to negotiate stairs. Her resting pulse rate was 120 per minute, but the heart and chest showed no abnormality on examination. She was severely breathless, with very poor abdominal and thoracic movement and striking activity of the accessory muscles of respiration, including the sternomastoids and scaleni. Her ptosis and facial weakness had not increased since her previous admission but her strength of grip was strikingly weak and she was quite unable to lift her arms from the bed. Her vital capacity could not be measured as she said she was unable to blow into the machine. 
Conclusions
There seems to be little doubt whatever that this patient was suffering from a relatively benign, probably congenital, non-progressive myopathy, showing certain features reminiscent of myasthenia gravis. Dr. McArdle's investigations revealed no apparent defect in carbohydrate metabolism, while we were unable to produce any evidence to indicate that alterations in serum potassium affected her muscular condition. Save for the " myasthenic" features, her condition corresponds closely to the " benign congenital myopathy " or myopathic form of amyotonia congenita described by Batten (1910) and Aldren Turner (1940 Turner ( , 1949 . However, Turner did not describe any fatiguability or apparent response to ephedrine or prostigmine therapy in his cases, nor were these features seen in the other cases of this type which were reviewed recently by one of us (Walton, 1956 ). On the other hand, it is evident that this patient was not suffering from true myasthenia gravis, in view of the failure to respond to tensilon, as well as the atypical clinical picture. Nevertheless, it must be admitted that she showed a considerable resistance to decamethonium iodide, while the sustained improvement on ephedrine therapy and the temporary response to prostigmine were suggestive of the latter disease. The apparent increase in strength following an injection of caffeine sodium benzoate was of doubtful significance.
Of great interest was the striking increase in weakness, particularly of the respiratory muscles, after prostigmine therapy had been in progress for some weeks.
The associated tachycardia was suggestive of vagal inhibition but it is difficult to see how moderate dosage of prostigmine, which would be expected to give a bradycardia, could produce this effect. It seems most probable that the weakness could be attributed to this drug, despite the absence of other side-effects, and that the temporary improvement, perhaps due to its anti-cholinesterase effect, was subsequently overcome by a persistent depolarizing effect which appeared to be cumulative. It is well recognized that even patients with myasthenia gravis may become weak as a result of excessive dosage of this drug (Rowland, Korengold, Jaffe, Berg, and Shy, 1955) (Walton and Nattrass, 1954 ) has referred to a number of cases of " myasthenic myopathy ". This term is probably unsatisfactory, as it could be taken to refer to the irreversible muscular weakness and atrophy which may develop in the limb or ocular muscles of certain long-standing cases of myasthenia gravis. One of us (J. A. S.) in a recent study of a large series of cases of the latter condition has come to feel that such changes occur in a not insignificant proportion of cases and may follow a recognizable pattern, particularly in the limb muscles. However, the three cases briefly referred to by Walton and Nattrass (1954) were not of this type; rather, they were individuals with a long-standing weakness and atrophy of girdle and limb muscles who yet showed a somewhat phasic course and a definite, though sometimes temporary, response to ephedrine and/or prostigmine. Similar patients with a clinical picture like a combination of muscular dystrophy and myasthenia gravis have been reported by Laruelle and Massion-Verniory (1937) , by Jezkova and Sachs (1939) and by Hosotte (1951) . Hosotte's case, however, may have been one of true myasthenia gravis with eventual amyotrophy. In none of the cases mentioned by Walton and Nattrass did the condition begin so soon after birth as in the patient described in the present report. It is of considerable interest that one of these patients, shortly to be reported by Griffin, Nattrass, and Pask (1956) , was given increasing doses of prostigmine with apparent improvement in the power of the limbs, but with eventual respiratory paralysis, necessitating management with intermittent positive-pressure respiration. He was subsequently subjected to thymectomy with dramatic improvement.
It must be concluded that there exist a number of obscure disorders falling into the borderland of both myopathy and myasthenia gravis, of which the present case is a striking example. We have at present, however, no information to indicate the the nature of the basic muscular defect in such individuals. Summary The case is reported of a woman who developed muscular weakness and hypotonia in the first year of life; she has shown subsequently persistent though non-progressive weakness, with moderate diffuse atrophy of the upper facial, trunk, and limb muscles. Her weakness has always become worse after exertion and she has had slight dysphagia but no diplopia.
Extensive metabolic, electrophysiological, and therapeutic experiments have revealed no defect in carbohydrate utilization or in potassium metabolism. She is more resistant to decamethonium iodide than the normal individual and shows improvement on ephedrine therapy but none following tensilon. Prostigmine produces definite improvement in muscular power, but if continued indefinitely in moderate dosage it appears to produce an increase in weakness, particularly of the respiratory muscles. A muscle biopsy revealed only slight, indefinite changes compatible with a myopathic disorder.
It is suggested that this condition falls into a borderland of myopathy and myasthenia and that it should be styled " benign congenital myopathy with myasthenic features ". It was not possible to determine the nature of the biochemical or other defect in the muscle fibre and/or its end-plate or membrane which was responsible for this patient's condition.
